Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18648228 | MEDICAL CONNECTOR WITH ELONGATED PORTION WITHIN SEAL COLLAR | April 2024 | August 2024 | Allow | 3 | 1 | 0 | Yes | No |
| 18413701 | SYRINGE SUPPORT AND AUTOINJECTOR | January 2024 | May 2024 | Allow | 4 | 1 | 0 | No | No |
| 18567539 | Connector Assembly | December 2023 | May 2024 | Allow | 6 | 0 | 0 | No | No |
| 18141370 | SYSTEM AND METHODS FOR PERCUTANEOUS MECHANICAL AND/OR NEURAL INTERFACE | April 2023 | May 2024 | Allow | 13 | 1 | 1 | Yes | No |
| 18106278 | SYRINGE SUPPORT AND AUTOINJECTOR | February 2023 | July 2023 | Allow | 6 | 1 | 0 | Yes | No |
| 18067666 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | December 2022 | July 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 17999592 | SYSTEM AND METHOD FOR SYRINGE PLUNGER ENGAGEMENT WITH AN INJECTOR | November 2022 | February 2024 | Allow | 15 | 1 | 1 | No | No |
| 17999092 | IN-LINE AIR BUBBLE SUSPENSION APPARATUS FOR ANGIOGRAPHY INJECTOR FLUID PATHS | November 2022 | August 2023 | Allow | 9 | 1 | 0 | No | No |
| 17883430 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | August 2022 | July 2023 | Allow | 12 | 1 | 1 | No | No |
| 17845560 | SYSTEMS, APPARATUS, AND METHODS FOR FLUID INFUSION | June 2022 | May 2023 | Allow | 11 | 1 | 0 | Yes | No |
| 17842386 | IMPLANTABLE DRUG DELIVERY SYSTEMS, ASSEMBLIES, AND METHODS | June 2022 | April 2023 | Allow | 10 | 2 | 0 | No | No |
| 17749086 | APPARATUS, SYSTEM, AND METHOD FOR IMPLANTING SURGICAL MATERIAL | May 2022 | November 2023 | Allow | 18 | 4 | 0 | Yes | No |
| 17677548 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | February 2022 | April 2022 | Allow | 2 | 0 | 0 | No | No |
| 17666696 | SYRINGE SUPPORT AND AUTOINJECTOR | February 2022 | April 2022 | Allow | 3 | 0 | 0 | No | No |
| 17573769 | COUPLING APPARATUS FOR INFUSION DEVICE | January 2022 | January 2023 | Allow | 12 | 2 | 0 | Yes | No |
| 17557889 | WEARABLE INTRAVENOUS FLUID DELIVERY SYSTEM | December 2021 | March 2022 | Allow | 2 | 0 | 0 | Yes | No |
| 17521049 | PORT PROTECTOR AND COVER SYSTEM AND METHOD OF USE | November 2021 | August 2024 | Abandon | 33 | 2 | 0 | No | No |
| 17516540 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | November 2021 | June 2022 | Allow | 7 | 2 | 0 | Yes | No |
| 17466127 | Drive Mechanism for a Drug Delivery Device | September 2021 | January 2022 | Allow | 5 | 0 | 0 | No | No |
| 17400379 | MANUALLY OPERATED MECHANICAL PUMP FOR DRUG INFUSION | August 2021 | May 2024 | Allow | 33 | 1 | 0 | No | No |
| 17399514 | INJECTOR GUARD AND METHOD OF USE | August 2021 | June 2023 | Abandon | 23 | 3 | 0 | Yes | No |
| 17376589 | MEDICAL DEVICE HAVING NON-FILTERED CSF WITHDRAWAL PATHWAY | July 2021 | March 2024 | Allow | 32 | 2 | 0 | No | No |
| 17321119 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | May 2021 | November 2021 | Allow | 7 | 1 | 0 | No | No |
| 17308150 | CUFF DEVICE FOR ACCESSING PATIENT BLOOD VESSELS | May 2021 | February 2022 | Allow | 9 | 2 | 0 | No | No |
| 17244610 | VACCINE GENERATION | April 2021 | July 2022 | Allow | 14 | 2 | 1 | Yes | No |
| 17237299 | SECUREMENT DEVICES, SYSTEMS, AND METHODS | April 2021 | October 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17229157 | Disinfection Cap | April 2021 | June 2023 | Allow | 26 | 1 | 1 | Yes | No |
| 17217838 | CATHETER SECUREMENT DEVICE WITH WINDOW | March 2021 | October 2023 | Allow | 31 | 1 | 0 | No | No |
| 17272897 | ELASTOMER COMPONENTS CONTAINING TAGGANTS | March 2021 | October 2021 | Allow | 8 | 1 | 1 | Yes | No |
| 17186765 | SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICES | February 2021 | January 2024 | Allow | 35 | 1 | 0 | No | No |
| 17174194 | ASPIRATION CATHETER SYSTEMS AND METHODS OF USE | February 2021 | March 2021 | Allow | 2 | 0 | 0 | No | No |
| 17155297 | Syringe Actuated Stopcock Smart-Valve | January 2021 | April 2024 | Allow | 39 | 4 | 0 | Yes | No |
| 17154454 | PEN NEEDLE HUB HAVING INCREASED CONTACT AREA | January 2021 | May 2024 | Abandon | 40 | 2 | 0 | No | No |
| 17153850 | EAR-COVER STRUCTURE AND EAR IRRIGATION DEVICE | January 2021 | August 2021 | Allow | 7 | 1 | 0 | No | No |
| 17129107 | SYSTEMS, APPARATUS, AND METHODS FOR REDUCING FLUID PRESSURE IN A FLUID LINE | December 2020 | April 2024 | Allow | 40 | 1 | 0 | Yes | No |
| 17113268 | EXPANDABLE SHEATH AND METHODS OF USING THE SAME | December 2020 | September 2023 | Allow | 33 | 1 | 0 | Yes | No |
| 17096676 | Adaptor for a Drug Delivery Device and Drug Delivery Device | November 2020 | August 2023 | Allow | 33 | 1 | 0 | No | No |
| 17082872 | CATHETER HUB AND STRAIN RELIEF | October 2020 | July 2023 | Allow | 33 | 1 | 0 | Yes | No |
| 17075292 | MEDICAL DEVICE WITH A NESTED LAP JOINT AND A FUSED CONDUCTIVE ELEMENT AND METHOD FOR FABRICATING THE SAME | October 2020 | February 2024 | Allow | 40 | 2 | 0 | No | No |
| 17062718 | Single Dose Medicament Delivery Device | October 2020 | September 2023 | Allow | 35 | 1 | 0 | No | No |
| 17041621 | MEDICAMENT DELIVERY DEVICE, APPARATUS AND ASSEMBLY | September 2020 | February 2021 | Allow | 5 | 0 | 0 | No | No |
| 17025201 | ANTISEPTIC CAP | September 2020 | April 2024 | Allow | 43 | 2 | 0 | Yes | No |
| 17026163 | STERILIZED VASCULAR ACCESS ASSEMBLIES AND RELATED KITS AND METHODS | September 2020 | May 2023 | Abandon | 31 | 1 | 0 | No | No |
| 17016949 | AUTOMATIC DIALYSATE DETECTION IN DIALYSIS MACHINES | September 2020 | June 2023 | Allow | 33 | 1 | 0 | No | No |
| 17016153 | AUTOMATIC INJECTION DEVICE HAVING A MAGNETIC DRIVE SYSTEM | September 2020 | February 2024 | Allow | 42 | 1 | 0 | No | No |
| 17007458 | MEDICAL CONNECTOR | August 2020 | August 2023 | Allow | 36 | 1 | 0 | Yes | No |
| 17000486 | Medicament Delivery Device with Use Indicator | August 2020 | October 2023 | Allow | 38 | 2 | 0 | Yes | No |
| 17000870 | Medicament Delivery Device with Use Indicator | August 2020 | February 2024 | Allow | 41 | 2 | 0 | No | No |
| 16998701 | APPARATUS FOR PREVENTING BACKFLOW | August 2020 | January 2021 | Allow | 5 | 1 | 0 | Yes | No |
| 16998559 | PRE-FILLED SYRINGE | August 2020 | October 2023 | Allow | 38 | 2 | 0 | No | No |
| 16990878 | Advanced Electromagnetic Motion and Tracking Peripherally Inserted Central Venous Catheter System with Extended Endovascular Applications | August 2020 | June 2024 | Abandon | 46 | 2 | 0 | No | No |
| 16989560 | APPARATUS AND METHODS FOR INTRAVENOUS GAS ELIMINATION | August 2020 | February 2023 | Allow | 30 | 0 | 0 | No | No |
| 16932629 | COMPUTERIZED ORAL PRESCRIPTION ADMINISTRATION FOR SECURELY DISPENSING MEDICATION AND ASSOCIATED SYSTEMS AND METHODS | July 2020 | March 2024 | Allow | 44 | 2 | 0 | Yes | No |
| 16870377 | COLLAR AND ASSEMBLIES INCLUDING SAME, FOR APPLICATORS, SYRINGES AND THE LIKE | May 2020 | July 2023 | Allow | 38 | 2 | 0 | No | No |
| 16869009 | DUAL LUMEN IV ADMINISTRATION SET | May 2020 | August 2022 | Allow | 27 | 1 | 0 | No | No |
| 16860651 | Port Catheter | April 2020 | July 2022 | Allow | 27 | 1 | 0 | No | No |
| 16852268 | Drive Mechanism for a Drug Delivery Device | April 2020 | January 2023 | Allow | 33 | 0 | 0 | No | No |
| 16843993 | System for Delivering a Fluid to a Patient and for Detecting an Infusion Anomaly | April 2020 | August 2024 | Abandon | 53 | 0 | 1 | No | No |
| 16839107 | INGESTIBLE DEVICE FOR DELIVERY OF A DISPENSABLE SUBSTANCE | April 2020 | June 2023 | Allow | 39 | 2 | 0 | Yes | No |
| 16825591 | HYALINE CARTILAGE SHAPING | March 2020 | January 2023 | Abandon | 34 | 1 | 0 | No | No |
| 16806493 | RESORBABLE, DRUG-ELUTING SUBMUCOSAL TURBINATE IMPLANT DEVICE AND METHOD | March 2020 | January 2023 | Allow | 34 | 1 | 0 | No | No |
| 16803971 | METHOD AND APPARATUS FOR TREATMENT OF INTRACRANIAL HEMORRHAGES | February 2020 | January 2023 | Allow | 35 | 1 | 0 | No | No |
| 16799178 | METHODS FOR IMMUNE GLOBULIN ADMINISTRATION | February 2020 | February 2024 | Abandon | 47 | 1 | 0 | No | No |
| 16797831 | HIGH FLOW RATE ISOLATED INFUSION FOR REGIONAL TREATMENT OF CANCER AND MEDICAL CONDITIONS | February 2020 | June 2023 | Allow | 39 | 1 | 0 | No | No |
| 16797447 | Multiple Dosage Injector with Rack and Pinion Dosage System | February 2020 | December 2022 | Allow | 34 | 1 | 0 | No | No |
| 16612351 | CATHETER DEVICE | February 2020 | January 2023 | Allow | 39 | 2 | 0 | No | No |
| 16794146 | MEDICAL DEVICE SECUREMENT SYSTEM AND METHOD | February 2020 | October 2022 | Allow | 32 | 1 | 0 | No | No |
| 16791848 | LOW-FORCE PUMPING SEGMENT | February 2020 | October 2022 | Allow | 32 | 1 | 0 | No | No |
| 16788562 | COMPOUND CURVE NAVIGATION CATHETER | February 2020 | April 2023 | Allow | 38 | 2 | 0 | No | No |
| 16782751 | SAFETY PEN NEEDLES | February 2020 | January 2022 | Allow | 23 | 1 | 0 | No | No |
| 16780998 | T-SHAPED CATHETER | February 2020 | January 2024 | Abandon | 47 | 1 | 0 | No | No |
| 16745979 | Safety Device for Preventing Needle Stick Injury with a Needle of a Medical Device and Medical Device | January 2020 | December 2022 | Allow | 35 | 1 | 0 | No | No |
| 16629561 | PUMP DEVICE HAVING A HOLDING DEVICE FOR RECEIVING A SYRINGE | January 2020 | October 2021 | Allow | 21 | 0 | 0 | No | No |
| 16723896 | DELIVERY SYSTEM AND PROCESS | December 2019 | September 2023 | Abandon | 45 | 1 | 0 | No | No |
| 16723971 | Expandable Assembly Catheter | December 2019 | September 2023 | Allow | 45 | 3 | 0 | Yes | No |
| 16709645 | SMART OBTURATOR ASSEMBLY | December 2019 | September 2022 | Allow | 33 | 1 | 0 | No | No |
| 16707211 | MULTI-MIX INFUSION BAG | December 2019 | March 2023 | Allow | 39 | 2 | 0 | Yes | No |
| 16707874 | MEDICAL INJECTOR SYSTEM | December 2019 | October 2020 | Allow | 11 | 2 | 0 | Yes | No |
| 16706015 | SYSTEM AND METHOD FOR DELIVERING THERAPEUTIC AGENTS TO THE UTERINE CAVITY | December 2019 | June 2023 | Allow | 43 | 1 | 0 | Yes | No |
| 16676595 | SYSTEM AND METHOD FOR FLARED LUER CONNECTOR FOR MEDICAL TUBING | November 2019 | October 2022 | Abandon | 35 | 1 | 0 | No | No |
| 16675576 | DEVICES AND METHODS FOR A CANNULA-DELIVERED TREATMENT MATERIAL APPLICATION DEVICE | November 2019 | July 2022 | Allow | 32 | 2 | 0 | No | Yes |
| 16673036 | SYSTEMS AND METHODS FOR LUMBAR CEREBROSPINAL FLUID ACCESS AND TREATMENT | November 2019 | March 2020 | Allow | 4 | 1 | 0 | Yes | No |
| 16672745 | INTRATHECAL CATHETER WITH FEATURES TO REDUCE DRUG DISPERSION | November 2019 | February 2022 | Allow | 27 | 1 | 0 | No | No |
| 16673294 | CATHETER ASSEMBLY | November 2019 | January 2023 | Allow | 39 | 2 | 0 | Yes | No |
| 16671640 | CATHETER FOR RECOVERY OF DYSPHAGIA | November 2019 | January 2023 | Allow | 39 | 2 | 0 | No | No |
| 16671654 | CATHETER FOR RECOVERY OF DYSPHAGIA | November 2019 | December 2023 | Allow | 50 | 2 | 0 | Yes | No |
| 16607283 | NEEDLE SHIELD REMOVER | October 2019 | March 2022 | Allow | 29 | 2 | 0 | No | No |
| 16657089 | INFUSION DEVICE | October 2019 | June 2022 | Allow | 32 | 1 | 0 | No | No |
| 16599640 | SURGICAL ACCESS PORT | October 2019 | July 2022 | Allow | 33 | 1 | 0 | No | No |
| 16595181 | MEDICAL INJECTOR SYSTEM | October 2019 | October 2022 | Allow | 37 | 2 | 0 | No | No |
| 16591768 | ANTI-INFECTIVE PROTECTIVE DEVICE | October 2019 | December 2022 | Abandon | 39 | 2 | 0 | No | No |
| 16586067 | GRAFT-PORT HEMODIALYSIS SYSTEMS, DEVICES, AND METHODS | September 2019 | February 2023 | Allow | 41 | 2 | 0 | Yes | No |
| 16577986 | EAR CLEANING DEVICES AND METHODS | September 2019 | June 2020 | Allow | 9 | 2 | 0 | Yes | No |
| 16552240 | TUBE FOR MEDICAL INSTRUMENTS | August 2019 | May 2023 | Abandon | 44 | 1 | 0 | No | No |
| 16547952 | TREATMENT OF THE EAR | August 2019 | September 2021 | Allow | 24 | 1 | 0 | No | No |
| 16543066 | MEDICAL CONNECTOR | August 2019 | June 2023 | Allow | 46 | 2 | 0 | No | No |
| 16539569 | SYSTEMS, APPARATUS, AND METHODS FOR REDUCING FLUID PRESSURE IN A FLUID LINE | August 2019 | August 2020 | Allow | 12 | 2 | 0 | Yes | No |
| 16537058 | EXTERNAL DRUG PUMP | August 2019 | October 2022 | Allow | 39 | 2 | 0 | No | No |
| 16528094 | BOOT REMOVER | July 2019 | July 2022 | Abandon | 35 | 1 | 0 | No | No |
| 16523989 | SYSTEM AND METHOD FOR DELIVERING THERAPEUTIC AGENTS TO THE UTERINE CAVITY | July 2019 | July 2022 | Allow | 36 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LEE, BRANDY SCOTT.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 18.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner LEE, BRANDY SCOTT works in Art Unit 3783 and has examined 360 patent applications in our dataset. With an allowance rate of 89.4%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.
Examiner LEE, BRANDY SCOTT's allowance rate of 89.4% places them in the 69% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by LEE, BRANDY SCOTT receive 2.03 office actions before reaching final disposition. This places the examiner in the 67% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by LEE, BRANDY SCOTT is 35 months. This places the examiner in the 21% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +10.5% benefit to allowance rate for applications examined by LEE, BRANDY SCOTT. This interview benefit is in the 47% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 34.6% of applications are subsequently allowed. This success rate is in the 71% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 45.4% of cases where such amendments are filed. This entry rate is in the 63% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 76% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 90.0% of appeals filed. This is in the 81% percentile among all examiners. Of these withdrawals, 55.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 22.0% are granted (fully or in part). This grant rate is in the 12% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.